One of the hallmarks of GB is the abnormal expression of anti-apoptotic proteins such as BCL-2, which is associated with tumor survival and the resistance of malignant cells to radiotherapy and chemotherapy [65,66]. The gene discussed is BCL2; the disease is neoplasm.